431 related articles for article (PubMed ID: 12368672)
21. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
Moreau S; Saiag P; Aegerter P; Bosset D; Longvert C; Hélias-Rodzewicz Z; Marin C; Peschaud F; Chagnon S; Zimmermann U; Clerici T; Emile JF
Ann Surg Oncol; 2012 Dec; 19(13):4314-21. PubMed ID: 22772867
[TBL] [Abstract][Full Text] [Related]
22. Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.
Hoshimoto S; Faries MB; Morton DL; Shingai T; Kuo C; Wang HJ; Elashoff R; Mozzillo N; Kelley MC; Thompson JF; Lee JE; Hoon DS
Ann Surg; 2012 Feb; 255(2):357-62. PubMed ID: 22202581
[TBL] [Abstract][Full Text] [Related]
23. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
[TBL] [Abstract][Full Text] [Related]
24. Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: an immunologic survival model.
Jones RC; Kelley M; Gupta RK; Nizze JA; Yee R; Leopoldo Z; Qi K; Stern S; Morton DL
Ann Surg Oncol; 1996 Sep; 3(5):437-45. PubMed ID: 8876885
[TBL] [Abstract][Full Text] [Related]
25. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.
Callery C; Cochran AJ; Roe DJ; Rees W; Nathanson SD; Benedetti JK; Elashoff RM; Morton DL
Ann Surg; 1982 Jul; 196(1):69-75. PubMed ID: 7092355
[TBL] [Abstract][Full Text] [Related]
26. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
27. Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine.
Bystryn JC; Zeleniuch-Jacquotte A; Oratz R; Shapiro RL; Harris MN; Roses DF
Clin Cancer Res; 2001 Jul; 7(7):1882-7. PubMed ID: 11448900
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.
Coit DG; Rogatko A; Brennan MF
Ann Surg; 1991 Nov; 214(5):627-36. PubMed ID: 1953117
[TBL] [Abstract][Full Text] [Related]
29. The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis.
Danish HH; Patel KR; Switchenko JM; Gillespie TW; Jhaveri J; Chowdhary M; Abugideiri M; Delman KA; Lawson DH; Khan MK
Melanoma Res; 2016 Dec; 26(6):595-603. PubMed ID: 27575390
[TBL] [Abstract][Full Text] [Related]
30. Evidence for a better nodal staging system for melanoma: the clinical relevance of metastatic disease confined to the sentinel lymph nodes.
Reintgen M; Murray L; Akman K; Giuliano R; Lozicki A; Shivers S; Reintgen D
Ann Surg Oncol; 2013 Feb; 20(2):668-74. PubMed ID: 23054112
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant immunotherapy in melanoma with irradiated autologous tumor cells and low dose cyclophosphamide.
Elias EG; Suter CM; Fabian DS
J Surg Oncol; 1997 Jan; 64(1):17-22. PubMed ID: 9040795
[TBL] [Abstract][Full Text] [Related]
32. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node.
Jakub JW; Huebner M; Shivers S; Nobo C; Puleo C; Harmsen WS; Reintgen DS
Ann Surg Oncol; 2009 Aug; 16(8):2245-51. PubMed ID: 19517194
[TBL] [Abstract][Full Text] [Related]
33. Lymph node biopsy does not impair survival after therapeutic dissection for palpable melanoma metastases.
Kelemen PR; Wanek LA; Morton DL
Ann Surg Oncol; 1999 Mar; 6(2):139-43. PubMed ID: 10082037
[TBL] [Abstract][Full Text] [Related]
34. Metastatic melanoma to lymph nodes in patients with unknown primary sites.
Cormier JN; Xing Y; Feng L; Huang X; Davidson L; Gershenwald JE; Lee JE; Mansfield PF; Ross MI
Cancer; 2006 May; 106(9):2012-20. PubMed ID: 16568458
[TBL] [Abstract][Full Text] [Related]
35. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.
Agrawal S; Kane JM; Guadagnolo BA; Kraybill WG; Ballo MT
Cancer; 2009 Dec; 115(24):5836-44. PubMed ID: 19701906
[TBL] [Abstract][Full Text] [Related]
36. Autologous cell vaccine as a post operative adjuvant treatment for high-risk melanoma patients (AJCC stages III and IV). The new American Joint Committee on Cancer.
Lotem M; Peretz T; Drize O; Gimmon Z; Ad El D; Weitzen R; Goldberg H; Ben David I; Prus D; Hamburger T; Shiloni E
Br J Cancer; 2002 May; 86(10):1534-9. PubMed ID: 12085200
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of routine ilioinguinal lymph node dissection for palpable inguinal melanoma nodal metastasis.
Glover AR; Allan CP; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Br J Surg; 2014 Jun; 101(7):811-9. PubMed ID: 24752717
[TBL] [Abstract][Full Text] [Related]
38. BRAF mutation status is an independent prognostic factor for resected stage IIIB and IIIC melanoma: implications for melanoma staging and adjuvant therapy.
Barbour AP; Tang YH; Armour N; Dutton-Regester K; Krause L; Loffler KA; Lambie D; Burmeister B; Thomas J; Smithers BM; Hayward NK
Eur J Cancer; 2014 Oct; 50(15):2668-76. PubMed ID: 25070294
[TBL] [Abstract][Full Text] [Related]
39. Lymph node density vs. the American Joint Committee on Cancer TNM nodal staging system in node-positive bladder cancer in patients undergoing extended or super-extended pelvic lymphadenectomy.
Lee D; Yoo S; You D; Hong B; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY; Jeong IG
Urol Oncol; 2017 Apr; 35(4):151.e1-151.e7. PubMed ID: 28139370
[TBL] [Abstract][Full Text] [Related]
40. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
